The T2D trial showed a similar safety profile, with SAEs occurring in 48% of participants at the retatrutide groups vs
This triple action explains why clients not only lose weight but also describe a shift in their relationship with food
Our skilled nurse practitioners will work closely with you to monitor your progress and ensure your safety throughout your weight loss journey
Cardio and protein matter, but if we had to prioritize, lifting weights changes physiology in ways that resistance training uniquely supports especially when someone is using appetite-suppressing medications or is at risk for sarcopenia
Today, GLP-1 drugs improve blood sugar control and promote weight loss, transforming metabolic disease management
With clinically meaningful weight loss and cardiovascular outcomes in patients with type 2 diabetes, GLP-1RAs were further assessed in patients with overweight or obesity without type 2 diabetes in the 2021 STEP-1 trial and 2022 SURMOUNT-1 trial